Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
5.00
-0.56
-11.20%
Share Warrants & Outstandings
Total Reserve
8.35
3.12
5.23
167.63%
Shareholder's Funds
12.79
8.11
4.68
57.71%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.70
0.00
0.70
0.00%
Secured Loans
0.70
0.00
0.70
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.16
0.28
-0.44
-157.14%
Other Long Term Liabilities
0.00
0.58
-0.58
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.24
0.17
0.07
41.18%
Total Non-Current Liabilities
0.77
1.03
-0.26
-25.24%
Current Liabilities
Trade Payables
3.25
0.01
3.24
32,400.00%
Other Current Liabilities
0.88
0.15
0.73
486.67%
Short Term Borrowings
6.61
0.00
6.61
0.00%
Short Term Provisions
0.50
0.48
0.02
4.17%
Total Current Liabilities
11.24
0.64
10.60
1,656.25%
Total Liabilities
24.81
9.78
15.03
153.68%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.01
2.05
15.96
778.54%
Less: Accumulated Depreciation
7.63
0.91
6.72
738.46%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.38
1.14
9.24
810.53%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.47
0.58
1.89
325.86%
Long Term Loans & Advances
0.58
0.00
0.58
0.00%
Other Non Current Assets
0.04
0.00
0.04
0.00%
Total Non-Current Assets
13.46
1.72
11.74
682.56%
Current Assets Loans & Advances
Current Investments
0.00
0.01
-0.01
-100.00%
Inventories
5.02
0.10
4.92
4,920.00%
Sundry Debtors
5.28
0.02
5.26
26,300.00%
Cash and Bank
0.63
7.32
-6.69
-91.39%
Other Current Assets
0.07
0.34
-0.27
-79.41%
Short Term Loans and Advances
0.34
0.28
0.06
21.43%
Total Current Assets
11.34
8.06
3.28
40.69%
Net Current Assets (Including Current Investments)
0.10
7.42
-7.32
-98.65%
Total Current Assets Excluding Current Investments
11.34
8.05
3.29
40.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
24.81
9.78
15.03
153.68%
Contingent Liabilities
1.61
0.00
1.61
0.00%
Total Debt
7.30
0.00
7.30
0.00%
Book Value per share (adjusted)
28.80
16.24
12.56
77.34%
Annual - Borrowings
Borrowings 7.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Annual - Investments
Investments 2.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Annual - Current Assets
Current Assets 11.34 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025